Ulcerative Colitis
4 competing products in clinical development for Ulcerative Colitis.
Pipeline by Phase
Phase 21
Phase 32
Approved1
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Azathioprine + Placebo | Celltrion | Approved | Terminated | 85 |
| Mirikizumab SC + Mirikizumab IV + Placebo SC | Eli Lilly | Phase 3 | Completed | 77 |
| CT-P13 SC (Infliximab) | Celltrion | Phase 3 | Completed | 77 |
| Mirikizumab | Eli Lilly | Phase 2 | Completed | 52 |